Dr. Peter Hirth - Kinemed
Dr. Peter Hirth has joined Kinemed’s Board of Directors, bringing over 25 years of biotechnology and pharmaceutical discovery and development experience to the firm.
Hirth was the co-founder and CEO of Plexxikon from 2001, leading the firm through its acquisition by Daiichi Sanky in 2011.
He said: “KineMed holds a dominant intellectual property position, placing it at the forefront in unifying systems biology for decision making. I look forward to lending my experience and perspective to the management team as KineMed applies its broad platform to its innovative commercial offerings.”